GLP-1 Discontinuation: What It Means for Weight Loss Brands

How Niches Will Shape the Crowded Weight Management Market

The Future of Obesity Care: GLP-1s, Compounding & Surgery Trends

Huddle #Trends

Are Continuous Glucose Monitors Worth It for Those Without Diabetes?

23andMe’s New GLP-1 Service: Exploring Compounded Medications

Dexcom and Abbott’s FDA-Cleared CGMs: A Consumer Market Revolution

Navigating Obesity Care in the Digital Age

Huddle+ | Huddle #Trends

Compounding Pharmacy

Healthcare Concepts

Semaglutide: A Medical Marvel or an Economic Enigma?

I Was Right (and Wrong) About the Weight Management Space

Do Weight-management Startups Have a Future?

The Future of Obesity Care

Eli Lilly’s To-Be Blockbuster Anti-Obesity Drug Receives Fast-Track Designation

The Next Frontier of Weight Loss